2023
DOI: 10.17582/journal.aavs/2023/11.4.526.538
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Pioglitazone Against Ehrlich Solid Carcinoma Mice Model Through Antiproliferative and Antiangiogenic Pathways

Abstract: C ancer is the second prominent cause of death globally, also prevalence is expected to increase by 2040 due to the increase in the new cases of malignancy annually (Bray et al., 2018). Chemotherapeutic medications are extensively used in cancer treatment either alone or with radiotherapy and surgical interventions. Cisplatin, one of the antineoplastic alkylating agents, has a significant proven efficacy against many types of malignancies, such as the neck, ovaries, testes, and lung cancers (Al-Eitan et al., 2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 47 publications
(54 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?